Quarterly ResultApr 30, 2026, 04:26 PM
KIDS Q1 Revenue $59.4M; FY26 Guidance $263-267M
AI Summary
OrthoPediatrics Corp. reported Q1 2026 revenue of $59.4 million, a 13% increase year-over-year, with Adjusted EBITDA turning positive at $2.2 million. The company maintained its full-year 2026 revenue guidance of $263.0 million to $267.0 million and expects to achieve breakeven free cash flow. These figures are part of an investor presentation to be used by executive officers.
Key Highlights
- Q1 2026 Revenue increased 13% YoY to $59.4M.
- Q1 2026 Adjusted EBITDA was $2.2M, up from ($0.4M) YoY.
- Q1 2026 Net Loss remained at ($10.7M).
- Q1 2026 U.S. revenue was $45.3M; International revenue was $14.1M.
- FY2026 Revenue guidance set at $263.0M to $267.0M.
- FY2026 Adjusted EBITDA guidance is approximately $25.0M.
- FY2026 Free Cash Flow is expected to be breakeven.
Price Impact
More from KIDS